A genomic assay may predict long-term prognosis in premenopausal patients with HR+ early-stage breast cancer

HER2DX confirms the ability of the test to predict long-term survival and response to anti-HER2 therapy in BC

The future of precision oncology

The concept of pan-tumour therapeutics

Access to Oncology Medicines Coalition - The Medicines Patent Pool

Intraoperative ultrasound is accurate for guiding breast conservative surgery in non-palpable ductal breast carcinoma

Cloud software for helping build quality assurance in radiotherapy

UICC / WHO Policy dialogue: Maintaining cancer care in times of conflict and environmental emergencies

ARCHERY trial: Testing AI for radiotherapy

Systemic anti-cancer performance matrix

Increasing access to quality assured and affordable essential medicines for cancer care in LMICs

Addressing women’s cancers: an economic evaluation of breast and cervical cancer interventions in Kenya